Abstract: A polyacetal resin composition and a sliding member, the polyacetal resin composition having excellent performance with respect to friction/abrasion characteristics while maintaining good appearance of a molded article thereof or low occurrence of mold contamination during molding. The polyacetal resin composition contains at least (A) 100 parts by mass of a polyacetal resin, (B) 0.01 part by mass to 1 part by mass of a hindered-phenol-based antioxidant, (C) 0.3 part by mass to 5 parts by mass of silicone oil, (D) 0.1 part by mass to 1.0 part by mass of calcium carbonate, and (E) 0.02 part by mass to 0.2 part by mass of a fatty acid, the calcium carbonate (D) is precipitated calcium carbonate which is not surface-treated and which has an average particle diameter of 1?m or less, and the fatty acid (E) is a C12-30 fatty acid.

Abstract: The present disclosure relates to a low-combustibility film construction. The film construction includes a film layer, a first adhesive layer with a fire-retardant additive of at least 41% by weight and a second adhesive layer. The total thickness of the adhesive layers is in the range of 18.5 to 44.5 microns. The total thickness of the fire retardant adhesive layer is 32% to 85% of the total adhesive thickness.

Abstract: A stereoscopic image display apparatus which can accurately visually recognize all the regions of a stereoscopic image without using a varifocal lens, and can form a natural three-dimensional image on a retina with a processing load on a computer eased even if an image is viewed by a plurality of viewers from any positions.

Abstract: Provided is a 2H-chromene compound or a derivative thereof which has an excellent S1P1 agonist action. The 2H-chromene compound or derivative is particularly useful for preventing and/or treating a disease induced by undesirable lymphocyte infiltration or a disease induced by abnormal proliferation or accumulation of cells.

Abstract: Provided is a compound which has an excellent S1P1 agonist action, and is useful particularly as an active ingredient for an agent for preventing and/or treating a disease induced by undesirable lymphocyte infiltration or a disease induced by abnormal proliferation or accumulation of cells. According to the present invention, a 2H-chromene compound or a derivative thereof which has an excellent S1P1 agonist action, and is useful particularly as an active ingredient of an agent for preventing and/or treating a disease induced by undesirable lymphocyte infiltration or a disease induced by abnormal proliferation or accumulation of cells can be provided. The 2H-chromene compound and a derivative thereof which are the compounds of the present invention have an S1P1 agonist action, and can be used particularly for prevention and/or treatment of a disease induced by undesirable lymphocyte infiltration or a disease induced by abnormal proliferation or accumulation of cells.

Abstract: [Object] Provided is a compound which has an excellent S1P1 agonist action, and is useful particularly as an active ingredient for an agent for preventing and/or treating a disease induced by undesirable lymphocyte infiltration or a disease induced by abnormal proliferation or accumulation of cells. [Means for Solution] According to the present invention, a 2H-chromene compound or a derivative thereof which has an excellent S1P1 agonist action, and is useful particularly as an active ingredient of an agent for preventing and/or treating a disease induced by undesirable lymphocyte infiltration or a disease induced by abnormal proliferation or accumulation of cells can be provided. The 2H-chromene compound and a derivative thereof which are the compounds of the present invention have an S1P1 agonist action, and can be used particularly for prevention and/or treatment of a disease induced by undesirable lymphocyte infiltration or a disease induced by abnormal proliferation or accumulation of cells.

Abstract: To provide a useful compound as an active ingredient for a preventing and/or treating agent for rejection in the transplantation of an organ, bone marrow, or a tissue, an autoimmune disease, or the like, which has an excellent S1P1 agonist activity.

Abstract: A three-dimensional model modification system for modifying a three-dimensional model, defined by a plurality of surfaces and representing an arbitrary object is disclosed.

Abstract: Provided is a triarylcarboxylic acid derivative, or an isomer, a prodrug, a hydrate, a solvate, a polymorph, or a pharmaceutically acceptable salt thereof, represented by the following general formula (I): wherein A is an optionally substituted aryl or heteroaryl, and B is an optionally substituted monocyclic heteroaryl; and a pharmaceutical composition comprising the same and a pharmaceutically acceptable carrier. The triarylcarboxylic acid derivative (I) exhibits potent xanthine oxidase inhibiting action and is therefore useful as a therapeutic agent for preventing or treating hyperuricemia, gout, inflammatory bowel disease, diabetic nephropathy and diabetic retinopathy.

Abstract: [Problems] To provide a useful compound as an active ingredient for a preventing and/or treating agent for rejection in the transplantation of an organ, bone marrow, or a tissue, an autoimmune disease, or the like, which has an excellent S1P1 agonist activity.

Abstract: To provide a useful compound as an active ingredient for a preventing and/or treating agent for rejection in the transplantation of an organ, bone marrow, or a tissue, an autoimmune disease, or the like, which has an excellent S1P1 agonist activity.

Abstract: The present invention relates to a 2-phenylthiophene derivative or a salt thereof, wherein the thiophene ring is substituted with a carboxyl group or the like and the benzene ring has an electron-withdrawing group such as a cyano group and an electron-donating group such as a substituted alkoxy group at the same time. Since the compound of the invention has good xanthine oxidase-inhibitory action and uric acid-lowering action and does not have a structure derived from nucleic acid, the compound has advantages of high safety and excellent effects as compared with conventional compounds and is useful as a therapeutic or preventive agent for hyperuricemia, gout, inflammatory bowel diseases, diabetic kidney diseases, diabetic retinopathy, or the like.

Abstract: A three-dimensional model modification system for modifying a three-dimensional model, defined by a plurality of surfaces and representing an arbitrary object is disclosed.

Abstract: [Problems] To provide a useful compound as an active ingredient for a preventing and/or treating agent for rejection in the transplantation of an organ, bone marrow, or a tissue, an autoimmune disease, or the like, which has an excellent S1P1 agonist activity.

Abstract: Provided is a triarylcarboxylic acid derivative, or an isomer, a prodrug, a hydrate, a solvate, a polymorph, or a pharmaceutically acceptable salt thereof, represented by the following general formula (I): wherein A is an optionally substituted aryl or heteroaryl, and B is an optionally substituted monocyclic heteroaryl; and a pharmaceutical composition comprising the same and a pharmaceutically acceptable carrier. The triarylcarboxylic acid derivative (I) exhibits potent xanthine oxidase inhibiting action and is therefore useful as a therapeutic agent for preventing or treating hyperuricemia, gout, inflammatory bowel disease, diabetic nephropathy and diabetic retinopathy.

Abstract: A stereoscopic image display apparatus which can accurately visually recognize all the regions of a stereoscopic image without using a varifocal lens, and can form a natural three-dimensional image on a retina with a processing load on a computer eased even if an image is viewed by a plurality of viewers from any positions.

Abstract: The present invention relates to a 2-phenylthiophene derivative or a salt thereof, wherein the thiophene ring is substituted with a carboxyl group or the like and the benzene ring has an electron-withdrawing group such as a cyano group and an electron-donating group such as a substituted alkoxy group at the same time. Since the compound of the invention has good xanthine oxidase-inhibitory action and uric acid-lowering action and does not have a structure derived from nucleic acid, the compound has advantages of high safety and excellent effects as compared with conventional compounds and is useful as a therapeutic or preventive agent for hyperuricemia, gout, inflammatory bowel diseases, diabetic kidney diseases, diabetic retinopathy, or the like.

Abstract: The invention relates to a compound useful as remedies or preventives for IKK2-related inflammatory diseases or autoimmune diseases, or that is, a 2-aminopyrimidine derivative having a 2-hydroxyphenyl group at the 6-position thereof and having a saturated cyclic group that contains one nitrogen atom, such as piperidine, at the 4-position thereof. The pharmaceutical composition of the invention and the compound of the invention have an excellent antiinflammatory effect based on the IKK2-inhibitory effect thereof, and are therefore useful for remedies and preventives for inflammatory diseases and autoimmune diseases, especially for rheumatoid arthritis.

Abstract: Cellulose solvents, cellulose compositions, and methods of making and using the same. For example, a cellulose composition including cellulose dissolved in the following solvent: an amine-based composition, provided however, the amine-based composition is not ammonia; and a salt selected from the group including a thiocyanate salt, a halide salt, and a nitrate salt. Representative amine-based compositions include hydrazine, hydrazine hydrate, and ethylenediamine.

Abstract: Cellulose solvents, cellulose compositions, and methods of making and using the same. For example, a cellulose composition including cellulose dissolved in the following solvent: an amine-based composition, provided however, the amine-based composition is not ammonia; and a salt selected from the group including a thiocyanate salt, a halide salt, and a nitrate salt. Representative amine-based compositions include hydrazine, hydrazine hydrate, and ethylenediamine.